Pain management issues continue to be a problem for oncologists and their patients

This doesn't surprise me.  But it is absolutely something which needs to be fixed...

Cancer Doctors Still Not Great With Patients' Pain

It remains under-recognized and under-treated, survey finds

 

By Jenifer Goodwin
HealthDay Reporter

THURSDAY, Nov. 17 (HealthDay News) -- Oncologists think they are good at managing cancer patients' pain, but a new survey shows otherwise.

In response to two hypothetical vignettes describing a cancer patient who was suffering from pain, the majority of oncologists offered up a treatment plan that pain specialists would consider "unacceptable."

"There are serious deficiencies in oncologists' knowledge of cancer pain management," said study author Brenda Breuer, director of epidemiologic research in the department of pain medicine and palliative care at Beth Israel Medical Center in New York City.

The study appears in the Nov. 14 issue of the Journal of Clinical Oncology...

This article goes into quite a bit of detail and is worth a look.  CLICK-HERE to read more.

Feel good and keep smiling!  Pat

BREAKING NEWS: Cancer survivors are far more likely to relapse than experience a different type of secondary cancer...

This U.S. News and World Report article points-out that the majority of cancer patients who experience cancer for a second time relapse.  Only about 15% of secondary cancers are different from the first:

Second Cancer Often Same Type as the First, Study Finds

Risk varies depending on original disease, Danish researchers report 

MONDAY, November, 28, 2011 -- If cancer survivors develop a second cancer, it's most likely to be the same type of cancer as the first, researchers report.

About 15 percent of cancer survivors worldwide are diagnosed with a second primary cancer, the authors of the new report pointed out...

Read more about what I found to be confusing, contradictory statistics by CLICKING HERE.

Feel good and keep smiling!  Pat

New cancer drug delivery system performs well in latest clinical trial

Better delivery system apparently found for experimental ovarian cancer drug, GAP-107B8.

Although the drug is still in pre-clinical development, researchers are hopeful it may eventually be used to fight pancreatic, colorectal, gastric, and liver cancers, too.

Click-on the headline link below to read the report I found on ProactiveInvestors.com:

PharmaGap cancer drug achieves 3 key clinical testing elements in pre-clinical trial

Feel good and keep smiling!  Pat

Click-on the headline link below to read about Maggie Daley's valiant fight against breast cancer...

Former Chicago First Lady Dies at 68

By AP Thursday, Nov. 24, 2011